首页> 外文期刊>Medical science monitor : >Randomized clinical trial comparing the efficacy and safety of Augmentin versus cefuroxime in the treatment of chronic sinusitis in adult patients
【24h】

Randomized clinical trial comparing the efficacy and safety of Augmentin versus cefuroxime in the treatment of chronic sinusitis in adult patients

机译:比较Augmentin与头孢呋辛治疗成人慢性鼻窦炎的疗效和安全性的随机临床试验

获取原文
           

摘要

The purpose of the study was to compare the efficiency and tolerance of Augmentin¨ and cefuroxime in the treatment of chronic maxillary sinusitis based on clinical and bacteriological results. A group of l15 adults with radiographically and clinically confirmed maxillary sinusitis constituted the study group. The safety of the antimicrobials was also analyzed. Patients underwent maxillary sinus aspiration twice. . Prior to the initiation of treatment sinus fluid was aspirated and sent to the laboratory. Patients were then randomized to treatment with either Augmentin¨ or cefuroxime. A second sinus puncture was performed at the end of the fourteen-day treatment. Microbiological assessment was performed again. The clinical cure rate for Augmentin¨ and cefuroxime was determined to be 98.2% and 91.1%, respectively. No significant dependence in efficacy between the two antibiotics was shown by Fisher's exact test (p=0.20). Microbiological cure was about 69%. The results indicate good efficacy for both antibiotics in the treatment of chronic sinusitis and similar very acceptable clinical tolerance
机译:这项研究的目的是根据临床和细菌学结果比较Augmentin®和头孢呋辛在慢性上颌窦炎治疗中的效率和耐受性。一组在放射学和临床上均已确认上颌窦炎的15例成年人组成了研究组。还分析了抗菌剂的安全性。患者接受了两次上颌窦抽吸术。 。在开始治疗之前,将鼻窦液吸出并送至实验室。然后将患者随机分配接受Augmentin®或头孢呋辛治疗。在第十四天治疗结束时进行了第二次鼻窦穿刺。再次进行微生物评估。 Augmentin®和头孢呋辛的临床治愈率分别确定为98.2%和91.1%。 Fisher精确检验未显示两种抗生素在功效上的显着相关性(p = 0.20)。微生物治愈率约为69%。结果表明两种抗生素在治疗慢性鼻窦炎方面均具有良好的疗效,并且具有相似的非常可接受的临床耐受性

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号